(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADOS DE TRIAZINONA COMO INIBIDORES DE NLRP3

Em AnáliseInvention PatentPCT · EP2023080902

Application data

Number

112025008888

Type

Invention Patent

Filing

11/07/2023

Publication

12/09/2025

PCT

EP2023080902

Progress at the INPI

Examination not yet requested
  1. Filing11/07/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

Examination has not been requested yet. Without that request by 11/07/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).

Deadline to request examination:11/07/2026(74 days left)

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 12/09/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

F. HOFFMANN-LA ROCHE AG

CH

See this company's full portfolio

Inventors

G. J. (pessoa física)

CH

J. S. (pessoa física)

GB

L. B. (pessoa física)

CH

S. M. (pessoa física)

CH

W. G. (pessoa física)

CH

Technical data

Priority claims

EP

22206287.9 · 11/09/2022

Abstract

DERIVADOS DE TRIAZINONA COMO INIBIDORES DE NLRP3. A invenção se refere a um novo composto com a fórmula 6-[[(3R)-1-Etil-3-piperidil]amino]-3-(4-hidroxi-indan-5-il)-4-metil-1,2,4-triazin-5-ona ou 6-[[(3R)-1-etil-3-piperidil]amino]-3-(2-hidroxi-3-biciclo[4.2.0]octa-1,3,5-trienil)-4-metil-1,2,4-triazin-5-ona, e sais farmaceuticamente aceitáveis destes, composições incluindo o composto e métodos de uso do composto.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

12/09/2025

RPI 2866

Alteração de dados cadastrais

#1.1

06/10/2025

RPI 2840

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.